DUBLIN--(BUSINESS WIRE)--The "Global Nuclear Medicine Isotopes Market 2021-2027" report has been added to ResearchAndMarkets.com's offering.
The global nuclear medicine isotope market is anticipated to grow at a considerable CAGR during the forecast period.
The growing usage of nuclear medicine isotopes in treatment of several disorders is a key factor driving the growth of the global nuclear medicine isotopes market. Nuclear medicine is used to diagnose and test the effect of a wide range of diseases, including heart diseases, tumors, gastrointestinal, neurological disorders, and endocrine disorders, as well as other abnormalities in the body.
The global nuclear medicine isotope market is segmented based on type and application. Based on type, the market is segmented into stable isotopes and radio isotopes. Based on application, the nuclear medicine isotope market is segmented into nuclear therapy, equipment radioactive source, and diagnosis.
Geographically, the global nuclear medicine isotope market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World. Some of the companies operating in the global nuclear medicine isotope market include Bayer AG, General Electric Co., Siemens Healthcare, Cardinal Health, Inc., and Nordion Inc.
Market Segmentation
- Global Nuclear Medicine Isotope Market Research and Analysis by Type
- Global Nuclear Medicine Isotope Market Research and Analysis by Application
The Report Covers
- Comprehensive research methodology of the global nuclear medicine isotope market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global nuclear medicine isotope market.
- Insights about market determinants that are stimulating the global nuclear medicine isotope market.
- Detailed and extensive market segments with the regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
Key Topics Covered:
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Market Determinants
3.1. Motivators
3.2. Restraints
3.3. Opportunities
4. Market Segmentation
4.1. Global Nuclear Medicine Isotopes Market By Type
4.1.1. Stable Isotopes
4.1.2. Radio Isotopes
4.2. Global Nuclear Medicine Isotopes Market by Application
4.2.1. Nuclear Therapy
4.2.2. Equipment Radioactive Source
4.2.3. Diagnosis
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Advanced Accelerator Applications
6.2. Bayer AG
6.3. Bracco Imaging
6.4. Cardinal Health, Inc.
6.5. Curium
6.6. Eczacybay-Monrol Nuclear Products
6.7. GE Healthcare
6.8. Lantheus Medical Imaging
6.9. Nordion
6.10. NTP Radioisotopes
For more information about this report visit https://www.researchandmarkets.com/r/ee00sy
